Cardinal Health, Inc. (CAH) Stake Lowered by Aspiriant LLC
Aspiriant LLC lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 25.8% during the second quarter, Holdings Channel reports. The institutional investor owned 4,223 shares of the company’s stock after selling 1,466 shares during the period. Aspiriant LLC’s holdings in Cardinal Health were worth $329,000 as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. Advisory Services Network LLC purchased a new position in Cardinal Health during the first quarter worth approximately $120,000. JFS Wealth Advisors LLC boosted its position in Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after buying an additional 244 shares in the last quarter. Dupont Capital Management Corp purchased a new position in Cardinal Health during the second quarter worth approximately $164,000. Alpha Windward LLC boosted its position in Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares in the last quarter. Finally, MCF Advisors LLC boosted its position in Cardinal Health by 11.5% in the first quarter. MCF Advisors LLC now owns 2,478 shares of the company’s stock worth $202,000 after buying an additional 256 shares in the last quarter. 86.41% of the stock is owned by hedge funds and other institutional investors.
Shares of Cardinal Health, Inc. (NYSE CAH) opened at 66.01 on Thursday. The stock has a market capitalization of $20.89 billion, a PE ratio of 16.38 and a beta of 0.80. Cardinal Health, Inc. has a 52-week low of $62.70 and a 52-week high of $84.88. The firm has a 50-day moving average of $74.55 and a 200 day moving average of $76.72.
Cardinal Health (NYSE:CAH) last announced its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. Cardinal Health’s revenue was up 5.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.14 earnings per share. Equities research analysts forecast that Cardinal Health, Inc. will post $4.97 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Sunday, October 15th. Shareholders of record on Monday, October 2nd will be paid a dividend of $0.4624 per share. This represents a $1.85 annualized dividend and a yield of 2.80%. The ex-dividend date is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 45.79%.
ILLEGAL ACTIVITY NOTICE: “Cardinal Health, Inc. (CAH) Stake Lowered by Aspiriant LLC” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/17/cardinal-health-inc-cah-stake-lowered-by-aspiriant-llc.html.
A number of equities analysts recently commented on the stock. UBS AG reaffirmed a “neutral” rating and set a $76.00 price target (down from $79.00) on shares of Cardinal Health in a research note on Thursday, August 3rd. Credit Suisse Group reaffirmed an “outperform” rating and set a $87.00 price target (up from $81.00) on shares of Cardinal Health in a research note on Thursday, July 13th. William Blair cut shares of Cardinal Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 19th. Barclays PLC reaffirmed an “overweight” rating and set a $82.00 price target (down from $88.00) on shares of Cardinal Health in a research note on Saturday, April 22nd. Finally, BidaskClub cut shares of Cardinal Health from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $80.46.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.